Haifa/Frankfurt – September 11, 2026 -- Insightec has treated 10,000 patients across Europe, the Middle East and Africa with its Exablate Neuro platform for essential tremor and Parkinson's disease, a figure that has more than doubled over the past three years. The incisionless MR-guided focused ultrasound (MRgFUS) therapy is now available at more than 62 treatment centers in 20 countries across the region, part of a global network exceeding 30,000 patients treated at 226 centers worldwide.